Funding for this research was provided by:
National Natural Science Foundation of China (11704188)
China Postdoctoral Science Foundation (2019M651564)
the Natural Science Foundation of Jiangsu (BK 20170826)
Beijing Bethune Charitable Foundation (BJ-LM2019002J)
General Project of the National Natural Science (8190087)
the Natural Science Foundation of Jiangsu, China (BK20191059)
Bethune Langmu young and middle-aged Science Foundation (BJ-LM2019002J)
Received: 4 August 2020
Accepted: 5 January 2021
First Online: 22 January 2021
Ethics approval and consent to participate
: The trial has been registered with the Chinese Clinical Trial Registry (ExternalRef removed registration number: ChiCTR-IPR-17014160). The study has followed the tenets of the Declaration of Helsinki, and the study protocol has been approved by the Ethics Committee of First Affiliated Hospital of Nanjing Medical University (2015-SR-150). Informed written consents have been obtained from all patients after explaining possible consequences of the study.
: Not applicable.
: The authors declare that they have no competing interests.